A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
We will be joined by Daria Fedyukina, Ph.D., ARPA-H Program Manager, who specializes in translational science and commercialization strategies involving cell and gene therapies, and Stan Wang, M.D., Ph.D., Founder and CEO of Thymmune Therapeutics, which is leading the Thymus Rejuvenation project. The project aims to restore damaged or non-functional thymus tissue. The meeting is open only to official spokes of the network. Please log in to your member account to access the event registration link.